Palo Protocol

VIP + BPC-157

Immune

2 mg / 500 mcg · 30 capsules

Requested most often by the chronic-inflammatory-response community. We take that demand seriously enough not to shortcut the pathway.

Not available for purchase

What we know

Mechanism: Vasoactive intestinal peptide is an endogenous neuropeptide with immunomodulatory activity, paired here with BPC-157.
Evidence state: VIP has a substantial endogenous physiology literature; therapeutic supplementation evidence is limited.
Regulatory note: Contains BPC-157, on the FDA 503A Category 2 list. Prescriber pathway only.

Disclaimer

This product is not available for purchase. It has not been evaluated by the FDA and is not intended to diagnose, treat, cure or prevent any disease. Nothing on this page is medical advice. Palo lists this compound for transparency about our supply partnerships; any future availability would run through a licensed prescriber and a compounding pharmacy, not through this website.